These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 31003765)
1. Arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 via PKM2. Fan Z; He J; Fu T; Zhang W; Yang G; Qu X; Liu R; Lv L; Wang J Biochem Biophys Res Commun; 2019 Jun; 513(4):834-840. PubMed ID: 31003765 [TBL] [Abstract][Full Text] [Related]
2. ZnAs@SiO Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768 [No Abstract] [Full Text] [Related]
3. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma. Zheng T; Yin D; Lu Z; Wang J; Li Y; Chen X; Liang Y; Song X; Qi S; Sun B; Xie C; Meng X; Pan S; Liu J; Jiang H; Liu L Mol Cancer; 2014 May; 13():133. PubMed ID: 24884809 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells. Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635 [TBL] [Abstract][Full Text] [Related]
5. Pyruvate Kinase M2 Knockdown Suppresses Migration, Invasion, and Epithelial-Mesenchymal Transition of Gastric Carcinoma via Hypoxia-Inducible Factor Alpha/B-Cell Lymphoma 6 Pathway. Li N; Meng D; Xu Y; Gao L; Shen F; Tie X; Zhang Y; Yi Z; Shen W; Liu Z; Xu Z Biomed Res Int; 2020; 2020():7467104. PubMed ID: 33376737 [TBL] [Abstract][Full Text] [Related]
6. Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells. Cheng K; Hao M Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916907 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN. Zheng Q; Lin Z; Xu J; Lu Y; Meng Q; Wang C; Yang Y; Xin X; Li X; Pu H; Gui X; Li T; Xiong W; Lu D Cell Death Dis; 2018 Feb; 9(3):253. PubMed ID: 29449541 [TBL] [Abstract][Full Text] [Related]
8. EMT-related long non-coding RNA in hepatocellular carcinoma: A study with TCGA database. Zhang Z; Wang S; Liu W Biochem Biophys Res Commun; 2018 Sep; 503(3):1530-1536. PubMed ID: 30037433 [TBL] [Abstract][Full Text] [Related]
9. PKM2 regulates hepatocellular carcinoma cell epithelial-mesenchymal transition and migration upon EGFR activation. Fan FT; Shen CS; Tao L; Tian C; Liu ZG; Zhu ZJ; Liu YP; Pei CS; Wu HY; Zhang L; Wang AY; Zheng SZ; Huang SL; Lu Y Asian Pac J Cancer Prev; 2014; 15(5):1961-70. PubMed ID: 24716919 [TBL] [Abstract][Full Text] [Related]
10. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells. Cheng KY; Hao M Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy. Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107 [TBL] [Abstract][Full Text] [Related]
12. Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition. Feng B; Zhu Y; Sun C; Su Z; Tang L; Li C; Zheng G Int J Biol Macromol; 2019 Sep; 137():32-44. PubMed ID: 31252022 [TBL] [Abstract][Full Text] [Related]
13. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma. Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861 [TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells. Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus x protein induces epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating long non-coding RNA. Jin Y; Wu D; Yang W; Weng M; Li Y; Wang X; Zhang X; Jin X; Wang T Virol J; 2017 Dec; 14(1):238. PubMed ID: 29258558 [TBL] [Abstract][Full Text] [Related]
16. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo. Lu HY; Chu HX; Tan YX; Qin XC; Liu MY; Li JD; Ren TS; Zhang YS; Zhao QC Life Sci; 2020 Mar; 244():117343. PubMed ID: 31978449 [TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV inhibits cell migration and viability of hepatocellular carcinoma cells via suppressing long noncoding RNA ATB. Li Y; Ye Y; Chen H Biomed Pharmacother; 2018 Mar; 99():134-141. PubMed ID: 29331759 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of 3,3'4,4',5-pentachlorobiphenyl-induced epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Song L; Guo L; Li Z Toxicol Appl Pharmacol; 2017 May; 322():75-88. PubMed ID: 28284859 [TBL] [Abstract][Full Text] [Related]
19. LncRNA FUNDC2P4 down-regulation promotes epithelial-mesenchymal transition by reducing E-cadherin expression in residual hepatocellular carcinoma after insufficient radiofrequency ablation. Zeng J; Cai X; Hao X; Huang F; He Z; Sun H; Lu Y; Lei J; Zeng W; Liu Y; Luo R Int J Hyperthermia; 2018 Sep; 34(6):802-811. PubMed ID: 29295626 [TBL] [Abstract][Full Text] [Related]
20. Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor NFAT1. Dai W; Wang F; He L; Lin C; Wu S; Chen P; Zhang Y; Shen M; Wu D; Wang C; Lu J; Zhou Y; Xu X; Xu L; Guo C Mol Carcinog; 2015 Apr; 54(4):301-11. PubMed ID: 24243709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]